Treace Medical Concepts Inc expected to post a loss of 29 cents a share - Earnings Preview

Treace Medical Concepts

05/08/2025 21:16

Treace Medical Concepts Inc TMCI.OQ TMCI.O is expected to  show a rise in quarterly revenue when it reports  results on August 7 for the period ending June 30 2025

The Ponte Vedra Florida-based  company is expected to report a 5.8% increase in revenue to $47.053 million from $44.46 million a year ago, according to the mean estimate from 6 analysts, based on LSEG data.

​LSEG's mean analyst estimate for Treace Medical Concepts Inc is for a loss of 29 cents per share.

The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 2 "strong buy" or "buy," 4 "hold" and no "sell" or "strong sell."

The mean earnings estimate of analysts was unchanged in the last three months. ​

Wall Street's median 12-month price target for Treace Medical Concepts Inc is $9.00, about 37.7% above its last closing price of $5.61

Previous quarterly performance (using preferred earnings measure in US dollars). ​

QUARTER ENDING
STARMINESMARTESTIMATE®
LSEG IBES ESTIMATE
ACTUAL
BEAT, MET, MISSED
SURPRISE %
Mar. 31 2025
-0.30
-0.30
-0.25
Beat
17.1
Dec. 31 2025
-0.04
-0.04
-0.01
Beat
74.1
Sep. 30 2024
-0.27
-0.27
-0.25
Beat
8​
Jun. 30 2024
-0.29
-0.29
-0.29
Met
0
​​Mar. 31 2024
-0.30
-0.30
-0.30
Met
0.9
Dec. 31 2023
-0.09
-0.09
-0.10
Missed
-12.9​
Sep. 30 2023
-0.25
-0.26
-0.28
Missed
-7.1
Jun. 30 2023
-0.23
-0.24
-0.20
Beat
16.1

This summary was machine generated August 5 at 20:16 GMT.  All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)